Argenx Se (ARGX) Gross Profit (2022 - 2026)
Argenx Se's (ARGX) quarterly Gross Profit came in at $1.4 billion in Q2 2026, up 68.41% YoY from $837.8 million in Q2 2025, and up 19.88% on a QoQ basis from $1.2 billion in Q1 2026.
Argenx Se (ARGX) Gross Profit (2022 - 2026) Analysis & Trends
Argenx Se (ARGX) has 5 years of Gross Profit data on file, last reported at $1.4 billion in Q2 2026.
- Quarterly Gross Profit rose 68.41% year-over-year to $1.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.7 billion (up 74.0% YoY) and the FY2025 annual result came in at $3.8 billion, up 87.55% from the prior year.
- Gross Profit rose to $1.4 billion in Q2 2026, from $1.2 billion in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $1.4 billion in Q2 2026 to a low of $19.8 million in Q1 2022.
- A 5-year average of $538.4 million and a median of $390.2 million in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit jumped 908.98% — and 2026, when it jumped 66.01%.
- Tracing ARGX's Gross Profit over 5 years: stood at $160.6 million in 2022, then jumped by 108.5% to $334.9 million in 2023, then soared by 98.38% to $664.3 million in 2024, then surged by 71.01% to $1.1 billion in 2025, then climbed by 24.21% to $1.4 billion in 2026.
- The last three Gross Profit figures came in at $1.4 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.41 Bn |
| Jun 30, 2026 | 1.41 Bn |
| Mar 31, 2026 | 1.18 Bn |
| Mar 31, 2026 | 1.18 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.02 Bn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 837.85 Mn |
| Jun 30, 2025 | 837.85 Mn |
| Mar 31, 2025 | 709.00 Mn |
| Mar 31, 2025 | 709.00 Mn |
| Dec 31, 2024 | 664.31 Mn |
| Dec 31, 2024 | 664.31 Mn |
| Sep 30, 2024 | 513.93 Mn |
| Sep 30, 2024 | 513.93 Mn |
| Jun 30, 2024 | 425.25 Mn |
| Jun 30, 2024 | 425.25 Mn |
| Mar 31, 2024 | 355.11 Mn |
| Mar 31, 2024 | 355.11 Mn |